Up-to-date survival estimates and historical trends of cutaneous malignant melanoma in the south-east of The Netherlands
Esther de Vries(Tilburg University), J.W.W. Coebergh(Erasmus University Rotterdam), Saskia Houterman(Eindhoven Cancer Registry), M.L.G. Janssen‐Heijnen(Eindhoven Cancer Registry), S.A.M. van de Schans(Netherlands Comprehensive Cancer Organisation), Alexander M.M. Eggermont(University Medical Center Utrecht), Tamar Nijsten(Erasmus MC)
Cited by 58
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Final Version of 2009 AJCC Melanoma Staging and Classification
|Journal of Clinical Oncology|2009|4.6k
Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
|CA A Cancer Journal for Clinicians|2017|2.3k
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
|New England Journal of Medicine|2018|1.9k